Skip to main content
Clinical Trials/NCT06492382
NCT06492382WithdrawnNot Applicable

The Effects of Home Monitors Used with Home Oxygen Therapy: a Randomized Control Trial

University of New Mexico0 sites20 target enrollmentStarted: February 8, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
20
Primary Endpoint
Oxygen Wean

Study Overview

Brief Summary

This study's purpose is to determine the effects of using monitors with home oxygen therapy (HOT). This trial will test the hypothesis that infants discharged from the neonatal intensive care unit (NICU) with HOT will have a shorter treatment duration if used in conjunction with monitors.

Detailed Description

This will be a randomized control trial in which infants being discharged from the neonatal intensive care unit with home oxygen therapy will be placed in one of two groups. Those randomized into the treatment group will be sent home with a monitor to be used continuously during their need for supplemental oxygen. The control group will consist of infants randomized to receive the current standard of care, which is discharge with home oxygen and NO home monitor. The research team will contact the families of the subjects at one-month intervals to collect pertinent data.

Aim 1: Subjects will be randomly assigned to a control group (no home monitors, which is current clinical practice) and an experimental group (home monitors). The investigators will compare the duration of treatment with HOT between groups.

Aim 2: Obtain additional data from study participants to better understand the impact of home monitoring. This data includes frequency of adverse events (defined later in the protocol) including health care utilization, as well as parental quality of life, and altitude of the participant's home.

Exploratory Aim 1: Determine the perceptions of families regarding home monitor use.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •• Infants being discharged with home oxygen therapy.
  • •Infants born at other institutions and then transferred to UNMH will be eligible if discharged home with home oxygen therapy.
  • •Infants born at gestational age 28 0/7 weeks or greater.
  • •Infants of employees of the UNMH will be allowed to participate in the study but will not be targeted. All efforts will be made to ensure that no coercion or undue influence will be used in recruiting this population.

Exclusion Criteria

  • •• Infants diagnosed with conditions that will predispose them to prolonged hypoxemia; examples include cardiac anomaly, anatomic anomalies affecting the airway, tracheostomy dependency, cystic fibrosis, and trisomy
  • •Infants discharged with hospice care / palliative services.
  • •Infants discharged greater than 6 months after they were born.
  • •Parents less than 18 years old or prisoners.
  • •Parents who are unable to provide consent due to having a legal representative.
  • •Infants who are in foster care and/or are wards of the state.
  • •Families not fluent in English.

Arms & Interventions

Home oxygen monitor

Experimental

Infant will be on a home oxygen weaning guideline for their pediatrician to used based on information form the home oxygen monitor

Intervention: Home Oxygen Monitors (Diagnostic Test)

No Home oxygen monitor

Active Comparator

Infant will have a home oxygen weaning guideline for their pediatrician to use based on parameters other than a home oxygen monitor

Intervention: Home Oxygen Monitors (Diagnostic Test)

Outcomes

Primary Outcomes

Oxygen Wean

Time Frame: 1 -2 months

Length of time it takes infant to get off home oxygen

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dawn Walstrom Novak

Associate Professor of Pediatrics

University of New Mexico

Similar Trials